ABclonal Biotechnology

ABclonal is a biotechnology company dedicated to providing high-quality research tools for life science applications. Driven by a strong commitment to innovation and quality, ABclonal is leading the antibody revolution with its proprietary SMab Platform, which leverages advanced Single B Cell technology to develop next-generation rabbit monoclonal antibodies. This state-of-the-art platform overcomes the limitations of traditional antibody discovery and production, delivering exceptional specificity, sensitivity, and lot-to-lot consistency. With flexible engineering capabilities and an expanding library of application-ready clones, ABclonal is redefining the standards of performance and innovation in antibody research.